Order Article Reprints

Bao Y, Rong W, Zhu A, Chen Y, Chen H, Hong Y, Le J, Wang Q, Naman CB, Xu Z, et al. Retinoic Acid Receptor Is a Novel Therapeutic Target for Postoperative Cognitive Dysfunction. Pharmaceutics. 2023; 15(9):2311. https://doi.org/10.3390/pharmaceutics15092311

Bao, Yongjie, Wenni Rong, An Zhu, Yuan Chen, Huiyue Chen, Yirui Hong, Jingyang Le, Qiyao Wang, C. Benjamin Naman, Zhipeng Xu, and et al. 2023. "Retinoic Acid Receptor Is a Novel Therapeutic Target for Postoperative Cognitive Dysfunction" Pharmaceutics 15, no. 9: 2311. https://doi.org/10.3390/pharmaceutics15092311

Bao, Y., Rong, W., Zhu, A., Chen, Y., Chen, H., Hong, Y., Le, J., Wang, Q., Naman, C. B., Xu, Z., Liu, L., Cui, W., & Wu, X. (2023). Retinoic Acid Receptor Is a Novel Therapeutic Target for Postoperative Cognitive Dysfunction. Pharmaceutics, 15(9), 2311. https://doi.org/10.3390/pharmaceutics15092311